TODAY'S NEWS
Today, the U.S. Food and Drug Administration (FDA)...
On August 16, 2018, the U.S. Food and Drug Adminis...
A new study from the American Cancer Society has f...
An interim analysis of data from a randomized clin...
In a phase III Children’s Oncology Group stu...
More News From Today 
EDITORIALS & COMMENTARY
Enhanced recovery after surgery (ERAS) is a multimodal perioperative care pathway...
Lung cancer screening with low-dose computed tomography of the chest is now a service covered by...
Rituximab and hyaluronidase human is a new subcutaneous formulation of rituximab...
Tisagenlecleucel is a first-in-class chimeric antigen receptor (CAR)
T-cell therapy...
Often, advanced practitioners must give clinical presentations. Public speaking, which is a major fear...
More Editorials & Commentary 
